Key Takeaways on Wegovy Insurance Coverage
- FDA-approved for weight management: Wegovy (semaglutide 2.4mg) is approved for chronic weight management in adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity
- Commercial insurance coverage is expanding: About 40-50% of employer-sponsored plans now cover GLP-1 medications for weight loss, up from under 20% in 2023
- Medicare does NOT cover Wegovy for weight loss: Federal law prohibits Medicare Part D from covering drugs prescribed solely for weight management — no exceptions
- List price without insurance: Approximately $1,349/month ($16,188/year) at retail pharmacy
- Savings programs available: Novo Nordisk offers a savings card reducing cost to as low as $0-$25/month for eligible commercially insured patients
Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk. The FDA approved it in June 2021 specifically for chronic weight management — making it one of the first GLP-1 receptor agonists with an explicit obesity indication rather than just a diabetes label.
The coverage question is more complicated than it should be. Whether your insurance covers Wegovy depends on three things: the type of insurance you have (commercial vs government), whether your plan’s formulary includes GLP-1 medications for weight loss, and whether you meet the prior authorization criteria your insurer sets. Each of those layers can block access even when the drug is medically appropriate.
Which Insurance Plans Cover Wegovy?
Commercial (Employer-Sponsored) Insurance
Coverage is expanding but far from universal. Roughly 40-50% of large employer plans now include GLP-1 medications for weight management on their formulary, according to Mercer and Willis Towers Watson benefit surveys. The trend is clearly upward — driven by employer interest in reducing downstream healthcare costs from obesity-related conditions like diabetes, cardiovascular disease, and joint problems.
When covered, Wegovy typically sits on Tier 3 or Tier 4 (specialty tier) of the formulary. That means higher copays — often $100-$300/month even with coverage — and almost always a prior authorization requirement. Your doctor will need to document your BMI, prior weight-loss attempts, and comorbidities before the plan approves the prescription.
Plans that don’t cover Wegovy often have a blanket exclusion for “weight loss medications” or “anti-obesity drugs” in the benefit summary. Check your Summary Plan Description (SPD) or call the number on your insurance card and ask specifically about GLP-1 coverage for obesity.
ACA Marketplace Plans
Coverage varies by state and by plan. ACA plans are not required to cover weight loss medications under the essential health benefits mandate. Some state-based marketplace plans do include GLP-1 coverage; many don’t. Check your specific plan’s formulary before assuming coverage.
Medicare Part D
Medicare does not cover Wegovy when prescribed for weight loss. Section 1862(a)(1)(A) of the Social Security Act excludes drugs used for “anorexia, weight loss, or weight gain” from Part D coverage. This applies to all Medicare Part D plans, including Medicare Advantage plans with integrated Part D.
There is one exception: if Wegovy is prescribed for a covered indication other than weight loss (the drug has a separate FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and BMI ≥27), some Medicare plans may cover it under that indication. Your doctor would need to prescribe it specifically for cardiovascular risk reduction, not weight management.
Congressional legislation to allow Medicare coverage of weight loss drugs has been introduced repeatedly but has not passed as of May 2026.
Medicaid
Coverage varies by state. Most state Medicaid programs do not cover weight loss medications, though a growing number are adding GLP-1 coverage as the cost-effectiveness data improves. Check your state’s Medicaid formulary.
How Much Does Wegovy Cost Without Insurance?
| Scenario | Monthly Cost | Annual Cost |
|---|---|---|
| Retail price (no insurance) | ~$1,349 | ~$16,188 |
| With commercial insurance (covered) | $25–$300 | $300–$3,600 |
| With Novo Nordisk savings card (insured) | $0–$25 | $0–$300 |
| GoodRx/SingleCare coupon (cash pay) | ~$1,200–$1,350 | ~$14,400–$16,200 |
How To Get Wegovy Covered by Insurance
If your plan covers GLP-1 medications for weight management, here’s the process:
- Confirm formulary coverage: Call the pharmacy benefits number on your insurance card. Ask specifically: “Does my plan cover semaglutide (Wegovy) for weight management?” Get the answer in writing if possible.
- Meet prior authorization criteria: Most plans require documented BMI ≥30 (or ≥27 with comorbidities), evidence of prior weight-loss attempts (diet, exercise, sometimes previous medications), and a prescribing physician who documents medical necessity.
- Have your doctor submit the PA: The prescribing physician’s office submits the prior authorization to your insurer with supporting documentation. Turnaround is typically 3-10 business days.
- Appeal if denied: First-level denials are common and don’t always mean final “no.” A peer-to-peer review between your doctor and the insurer’s medical director overturns many initial denials. Request the specific denial reason in writing.
- Use step therapy if required: Some plans require you to try (and fail) a less expensive weight-loss medication before approving Wegovy. Completing the step therapy requirement — even if the prior medication didn’t work well — satisfies the coverage criteria.
Wegovy Savings Card and Patient Assistance
Novo Nordisk offers a manufacturer savings program that can reduce your out-of-pocket cost dramatically:
- Wegovy Savings Card: For commercially insured patients whose plan covers Wegovy. Reduces your copay to as low as $0 for the first 3 months, then $25/month thereafter. Maximum savings of $500/fill. Not available for Medicare, Medicaid, or government-insured patients.
- NovoCare Patient Assistance Program: For uninsured patients who meet income eligibility criteria (typically ≤400% of federal poverty level). May provide Wegovy at no cost for qualifying patients.
Enroll at wegovy.com or by calling NovoCare at 1-888-809-3942.
Wegovy vs Ozempic vs Mounjaro: Insurance Coverage Compared
| Medication | Manufacturer | FDA Approval | Insurance Coverage |
|---|---|---|---|
| Wegovy (semaglutide 2.4mg) | Novo Nordisk | Weight management + CV risk | ~40-50% of commercial plans; Medicare only for CV indication |
| Ozempic (semaglutide 1.0mg) | Novo Nordisk | Type 2 diabetes only | Widely covered for diabetes; NOT approved for weight loss (off-label use often denied) |
| Mounjaro (tirzepatide) | Eli Lilly | Type 2 diabetes | Widely covered for diabetes; weight-loss coverage expanding via Zepbound brand |
| Zepbound (tirzepatide) | Eli Lilly | Weight management | Newer entry; coverage expanding but less established than Wegovy |
Employee Benefits and GLP-1 Coverage Strategy
For employers evaluating whether to add GLP-1 medications to their benefits plan — or employees navigating coverage denials — Hotaling Insurance Services advises on employee benefits design, pharmacy benefit optimization, and appeals strategy.
Discuss Benefits OptionsFrequently Asked Questions
Does insurance cover Wegovy for weight loss?+
About 40-50% of commercial (employer-sponsored) insurance plans now cover Wegovy for weight management, typically with prior authorization required. Medicare does not cover Wegovy for weight loss. Medicaid coverage varies by state. Check your specific plan’s formulary by calling the pharmacy benefits number on your insurance card.
How much does Wegovy cost per month without insurance?+
Wegovy’s list price is approximately $1,349 per month ($16,188 per year). GoodRx and SingleCare coupons typically reduce this to $1,200-$1,350. The Novo Nordisk savings card can reduce the cost to $0-$25/month for commercially insured patients whose plan covers the medication.
Does Medicare cover Wegovy?+
Medicare Part D does not cover Wegovy when prescribed for weight loss. Federal law excludes weight loss drugs from Part D coverage. The only potential exception is if Wegovy is prescribed for cardiovascular risk reduction (its second FDA-approved indication) in patients with established cardiovascular disease and BMI ≥27. Congressional legislation to change this exclusion has been proposed but not enacted as of May 2026.
What is the difference between Wegovy and Ozempic?+
Both contain semaglutide but at different doses and for different indications. Ozempic is approved for type 2 diabetes at doses up to 2.0mg. Wegovy is approved for weight management at 2.4mg — a higher dose. Insurance coverage differs significantly: Ozempic is widely covered for diabetes but often denied for off-label weight loss use. Wegovy has an explicit weight loss indication, which makes it easier to get covered by plans that include anti-obesity medications.
How do I appeal a Wegovy insurance denial?+
Request the denial reason in writing from your insurer. Have your prescribing physician submit a letter of medical necessity documenting your BMI, comorbidities, prior weight-loss attempts, and why Wegovy is medically appropriate. Request a peer-to-peer review between your doctor and the insurer’s medical director. If the internal appeal fails, you can file an external appeal with your state’s insurance department. Many initial denials are overturned through this process.
Disclaimer: This article is for informational purposes only and does not constitute medical, pharmaceutical, or insurance advice. Wegovy is a prescription medication with potential side effects. Consult your healthcare provider before starting any medication. Insurance coverage terms change frequently — verify current coverage with your specific plan. Hotaling Insurance Services is not affiliated with Novo Nordisk.
Employee Benefits and Prescription Drug Strategy
Hotaling Insurance Services advises employers on employee benefits design including pharmacy benefit management, GLP-1 medication coverage strategy, and group health plan optimization. For employees navigating coverage questions, our licensed advisors can help you understand your options.
Contact Us$30.2M in employee benefits premium under management.